These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10410636)

  • 61. Temporal bone pathology in fetuses exposed to isotretinoin.
    Moerike S; Pantzar JT; De Sa D
    Pediatr Dev Pathol; 2002; 5(4):405-9. PubMed ID: 12016535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral treatment with ACCUTANE does not increase measures of anhedonia or depression in rats.
    Ferguson SA; Cisneros FJ; Hanig JP; Berry KJ
    Neurotoxicol Teratol; 2007; 29(6):642-51. PubMed ID: 17933491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isotretinoin-induced elkonyxis.
    Yung A; Johnson P; Goodfield MJ
    Br J Dermatol; 2005 Sep; 153(3):671-2. PubMed ID: 16120167
    [No Abstract]   [Full Text] [Related]  

  • 64. Tinea versicolor clearance with oral isotretinoin therapy.
    Bartell H; Ransdell BL; Ali A
    J Drugs Dermatol; 2006 Jan; 5(1):74-5. PubMed ID: 16468297
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prolonged thrombocytopenia associated with isotretinoin.
    Moeller KE; Touma SC
    Ann Pharmacother; 2003 Nov; 37(11):1622-4. PubMed ID: 14565796
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Drug information. Drugs and the fetus. 5].
    Rise A
    Ugeskr Laeger; 1976 Oct; 138(44):2729-30. PubMed ID: 969020
    [No Abstract]   [Full Text] [Related]  

  • 67. Temporary remission of disseminated granuloma annulare under oral isotretinoin therapy.
    Pasmatzi E; Georgiou S; Monastirli A; Tsambaos D
    Int J Dermatol; 2005 Feb; 44(2):169-71. PubMed ID: 15689223
    [No Abstract]   [Full Text] [Related]  

  • 68. Isotretinoin and teratogenicity.
    Strauss JS; Cunningham WJ; Leyden JJ; Pochi PE; Shalita AR
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 1):353-4. PubMed ID: 3170797
    [No Abstract]   [Full Text] [Related]  

  • 69. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
    Alcalay J; Landau M; Zucker A
    J Dermatolog Treat; 2001 Mar; 12(1):9-12. PubMed ID: 12171680
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute hip monoarthritis in a patient treated with isotretinoin.
    Pedraz T; Martínez A; Pascual E
    J Clin Rheumatol; 2006 Apr; 12(2):105-6. PubMed ID: 16601552
    [No Abstract]   [Full Text] [Related]  

  • 72. Safety and side effects of the acne drug, oral isotretinoin.
    Charakida A; Mouser PE; Chu AC
    Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isotretinoin and intestinal damage.
    Prescrire Int; 2008 Aug; 17(96):154-6. PubMed ID: 19492487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication.
    Rabello-Fonseca RM; Azulay DR; Luiz RR; Mandarim-de-Lacerda CA; Cuzzi T; Manela-Azulay M
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):115-23. PubMed ID: 18811602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Making the use of isotretinoin safer.
    Lane PR; Hogan DJ; Moreland AA
    CMAJ; 1989 Sep; 141(5):376. PubMed ID: 2766173
    [No Abstract]   [Full Text] [Related]  

  • 77. [List of factors with mutagenic and teratogenic effects on the fetus (drugs, chemical substances, ionizing radiation)].
    Kotásek A; Vanĕcek J; Stark O; Cervenka J; Svihovec V; Srám J
    Cesk Gynekol; 1983 Jul; 48(6):453-6. PubMed ID: 6616686
    [No Abstract]   [Full Text] [Related]  

  • 78. Teratogen may be implicated in lethal congenital syndrome.
    González ER
    JAMA; 1979 Sep; 242(11):1119-20. PubMed ID: 470053
    [No Abstract]   [Full Text] [Related]  

  • 79. Accutane Roche: risk of teratogenic effects.
    Zarowny DP
    Can Med Assoc J; 1984 Aug; 131(4):273. PubMed ID: 6589028
    [No Abstract]   [Full Text] [Related]  

  • 80. Babies, bath water, and accutane.
    Stone SP
    Clin Dermatol; 2001; 19(1):91-2. PubMed ID: 11369494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.